Ketoconazol Cf (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, preventing the synthesis of ergosterol, a key component of the fungal cell membrane. This disruption weakens the membrane, leading to increased permeability and ultimately fungal cell death.

The dosage of Ketoconazol Cf is determined by the prescribing healthcare professional based on the specific infection, its severity, patient age and the area of skin involved. Patients should follow the prescriber’s instructions and the product label.

Ketoconazol Cf should be used during pregnancy or while breastfeeding only if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should be consulted to evaluate safety on an individual basis.

To order Ketoconazol Cf, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoconazol Cf belongs to the azole class, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, azoles have a different mechanism targeting ergosterol synthesis and may be preferred for infections involving Malassezia species or when resistance to allylamines is a concern.

Ketoconazol Cf should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keeping the product at a stable, room‑temperature environment helps maintain its potency and safety.

Apply a thin layer of the cream or lotion to the affected skin area once or twice daily, as directed by a healthcare professional. The skin should be clean and dry before application, and hands should be washed after use to avoid accidental contact with eyes or mucous membranes.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and hepatotoxicity from systemic absorption. Patients should seek immediate medical attention if they experience symptoms like widespread rash, blistering, fever, jaundice or difficulty breathing.

Ketoconazol Cf should not be used by individuals with a known hypersensitivity to ketoconazole or other azole antifungals. It is also contraindicated on extensive broken skin, in patients with severe liver disease, or when used concurrently with certain systemic CYP3A4 inhibitors without medical supervision.